Form D · Other Health Care
NEPHROS INC
South Orange, NJ · CIK 001196298
Offering snapshot reported Dec 14, 2017 · SEC filing
- Reported sold
- $298K Offering amount: $10.2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 24, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 14, 2017 | Amendment | $297,500 | No comparison | 1 | SEC filing |
| Dec 13, 2017 | Amendment | $1,218,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-245144
Source: Form D, filed Dec 14, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arthur Amron | Director |
| Daron Evans | Director, Executive |
| Paul Mieyal | Director |
| Malcolm Persen | Director |
| Moshe Pinto | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
380 Lackawanna Place
South Orange, NJ, 07079
South Orange, NJ, 07079